Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

TBR-760 × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1

Interventions

Everolimus 55 lutetium Lu 177 dotatate 48 Magnetic Resonance Spectroscopy 32 Cisplatin 26 pembrolizumab 24 Temozolomide 24 gallium Ga 68 dotatate 21 Octreotide 21 lanreotide 20 Nivolumab 20 Specimen Handling 17 Capecitabine 17 3-Iodobenzylguanidine 17 cabozantinib 16 Etoposide 16 lenvatinib 15 Sunitinib 15 pasireotide 14 dabrafenib 14 Carboplatin 14 trametinib 13 surufatinib 13 Paclitaxel 13 Bevacizumab 13 Surgical Procedures, Operative 11 Doxorubicin 11 177Lu-octreotide, DOTA(0)-Tyr(3)- 11 Sorafenib 10 Radiotherapy 10 Ipilimumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04335357 2020-04-06

TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas

Tiburio Therapeutics

Phase 2 Unknown

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡